Moderna ETFs to Gain on New Positive COVID-19 Vaccine Data

by Sweta Jaiswal, FRM Published on August 28,2020

Per the latest data from an early stage clinical trial, Moderna's experimental coronavirus vaccine is successfully producing neutralizing antibodies and T-cells in older adults.

• MRNA Quick QuoteMRNANegative Net Change
• IBB Quick QuoteIBBPositive Net Change
• CNCR Quick QuoteCNCRPositive Net Change
• XBI Quick QuoteXBIPositive Net Change
• BBH Quick QuoteBBHPositive Net Change
• BTEC Quick QuoteBTECNegative Net Change
• IDNA Quick QuoteIDNAPositive Net Change
• GERM Quick QuoteGERMNegative Net Change

• biotechs
• etfs

Why Small-Cap Biotech ETFs Are Good Long-Term Bets

by Sanghamitra Saha Published on August 26,2020

Small-cap biotech ETFs may prove to be winning bets with or without coronavirus.

• BBC Quick QuoteBBCNegative Net Change
• BTEC Quick QuoteBTECNegative Net Change
• IDNA Quick QuoteIDNAPositive Net Change

• biotechs
• etfs

Moderna ETFs to Shine on U.S. Contracts for Coronavirus Vaccine

by Sweta Jaiswal, FRM Published on August 13,2020

Moderna has inked a $1.5-billion coronavirus vaccine supply agreement with the U.S. government.

• MRNA Quick QuoteMRNANegative Net Change
• IBB Quick QuoteIBBPositive Net Change
• CNCR Quick QuoteCNCRPositive Net Change
• XBI Quick QuoteXBIPositive Net Change
• BBH Quick QuoteBBHPositive Net Change
• BTEC Quick QuoteBTECNegative Net Change
• IDNA Quick QuoteIDNAPositive Net Change
• GERM Quick QuoteGERMNegative Net Change

• biotechs
• etfs

Moderna Turns Red Hot: Biotech ETFs to Bet On

by Sweta Killa Published on July 29,2020

Moderna skyrocketed 245% since it announced its COVID-19 vaccine candidate mRNA-1273 on Feb 10. The solid run is likely to continue as most of the analysts are optimistic on the stock.

• MRNA Quick QuoteMRNANegative Net Change
• IBB Quick QuoteIBBPositive Net Change
• CNCR Quick QuoteCNCRPositive Net Change
• XBI Quick QuoteXBIPositive Net Change
• BBH Quick QuoteBBHPositive Net Change
• BTEC Quick QuoteBTECNegative Net Change
• IDNA Quick QuoteIDNAPositive Net Change
• GERM Quick QuoteGERMNegative Net Change

• biotechs
• etfs

Moderna Inches Closer to Coronavirus Vaccine: ETFs to Shine

by Sweta Jaiswal, FRM Published on July 15,2020

Moderna plans to begin the Phase 3 study of mRNA-1273 this month.

• PFE Quick QuotePFENegative Net Change
• MRNA Quick QuoteMRNANegative Net Change
• IBB Quick QuoteIBBPositive Net Change
• CNCR Quick QuoteCNCRPositive Net Change
• XBI Quick QuoteXBIPositive Net Change
• BBH Quick QuoteBBHPositive Net Change
• FBT Quick QuoteFBTPositive Net Change
• BTEC Quick QuoteBTECNegative Net Change
• IDNA Quick QuoteIDNAPositive Net Change
• GERM Quick QuoteGERMNegative Net Change

• biotechs
• etfs

How to Tap Red-Hot Moderna Stock With ETFs

by Sweta Killa Published on July 15,2020

Moderna shares have surged more than 280% so far this year on the positive development of coronavirus vaccine.

• MRNA Quick QuoteMRNANegative Net Change
• IBB Quick QuoteIBBPositive Net Change
• CNCR Quick QuoteCNCRPositive Net Change
• XBI Quick QuoteXBIPositive Net Change
• BBH Quick QuoteBBHPositive Net Change
• BTEC Quick QuoteBTECNegative Net Change
• IDNA Quick QuoteIDNAPositive Net Change
• GERM Quick QuoteGERMNegative Net Change

• biotechs
• etfs

Top-Performing Biotechnology ETFs Amid Coronavirus Outbreak

by Sweta Jaiswal, FRM Published on July 13,2020

From vaccine-related progress to development of cell therapies for the treatment of coronavirus, all kept the rally in the biotech sector alive.

• BIB Quick QuoteBIBNegative Net Change
• XBI Quick QuoteXBIPositive Net Change
• ARKG Quick QuoteARKGPositive Net Change
• IDNA Quick QuoteIDNAPositive Net Change

• biotechs
• etfs

Invest in the Future With Megatrend ETFs

by Neena Mishra Published on June 25,2020

These ETFs invest in fast growing areas like robotics and AI, genomics and cybersecurity.

• REGN Quick QuoteREGNPositive Net Change
• GILD Quick QuoteGILDNegative Net Change
• MRNA Quick QuoteMRNANegative Net Change
• IRBO Quick QuoteIRBOPositive Net Change
• TECB Quick QuoteTECBPositive Net Change
• IHAK Quick QuoteIHAKPositive Net Change
• IDNA Quick QuoteIDNAPositive Net Change

• etf
• etfs

Moderna a Step Closer to Coronavirus Vaccine: ETFs to Gain

by Sweta Jaiswal, FRM Published on June 13,2020

Moderna informs that the final-stage trial's primary aim will be to prevent the spread of coronavirus.

• JNJ Quick QuoteJNJNegative Net Change
• AZN Quick QuoteAZNPositive Net Change
• MRNA Quick QuoteMRNANegative Net Change
• IBB Quick QuoteIBBPositive Net Change
• CNCR Quick QuoteCNCRPositive Net Change
• XBI Quick QuoteXBIPositive Net Change
• BBH Quick QuoteBBHPositive Net Change
• IDNA Quick QuoteIDNAPositive Net Change

• biotechs
• etfs

Profit from the Genomics Market Momentum With These ETFs

by Sweta Jaiswal, FRM Published on May 22,2020

Here we highlight some ETFs for gaining exposure to the genomics market that is currently buzzing with opportunities for investors to cash on.

• GSK Quick QuoteGSKPositive Net Change
• PBE Quick QuotePBEPositive Net Change
• ARKG Quick QuoteARKGPositive Net Change
• GNOM Quick QuoteGNOMPositive Net Change
• IDNA Quick QuoteIDNAPositive Net Change

• etfs
• genetics

Is Moderna Winning the COVID-19 Vaccine Race? ETFs to Gain

by Sweta Jaiswal, FRM Published on May 20,2020

Moderna has presented positive interim data from a phase I study evaluating its mRNA-based coronavirus vaccine candidate.

• JNJ Quick QuoteJNJNegative Net Change
• SNY Quick QuoteSNYPositive Net Change
• AZN Quick QuoteAZNPositive Net Change
• MRNA Quick QuoteMRNANegative Net Change
• GSK Quick QuoteGSKPositive Net Change
• NVAX Quick QuoteNVAXPositive Net Change
• IBB Quick QuoteIBBPositive Net Change
• CNCR Quick QuoteCNCRPositive Net Change
• XBI Quick QuoteXBIPositive Net Change
• BBH Quick QuoteBBHPositive Net Change
• IDNA Quick QuoteIDNAPositive Net Change

• biotechs
• etfs

Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners

by Sanghamitra Saha Published on April 24,2020

Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.

• GILD Quick QuoteGILDNegative Net Change
• IBB Quick QuoteIBBPositive Net Change
• CNCR Quick QuoteCNCRPositive Net Change
• BBH Quick QuoteBBHPositive Net Change
• FBT Quick QuoteFBTPositive Net Change
• PTH Quick QuotePTHPositive Net Change
• IHF Quick QuoteIHFNegative Net Change
• IHE Quick QuoteIHENegative Net Change
• XPH Quick QuoteXPHPositive Net Change
• SBIO Quick QuoteSBIOPositive Net Change
• XHS Quick QuoteXHSPositive Net Change
• PBE Quick QuotePBEPositive Net Change
• IDNA Quick QuoteIDNAPositive Net Change

• biotechs
• cancer
• etfs

Coronavirus Scare Supports These Biotech ETFs & Stocks

by Sanghamitra Saha Published on March 24,2020

Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.

• IBB Quick QuoteIBBPositive Net Change
• CNCR Quick QuoteCNCRPositive Net Change
• BBH Quick QuoteBBHPositive Net Change
• ARKG Quick QuoteARKGPositive Net Change
• AYTU Quick QuoteAYTUNegative Net Change
• FTSV Quick QuoteFTSVPositive Net Change
• VIR Quick QuoteVIRNegative Net Change
• IDNA Quick QuoteIDNAPositive Net Change
• CODX Quick QuoteCODXNegative Net Change
• CNTG Quick QuoteCNTGNegative Net Change

• biotechs
• etfs

11-Year Bull Market Nears an End? ETFs That Should Survive

by Sanghamitra Saha Published on March 10,2020

An oil collapse sent Wall Street into a tailspin on Mar 9, indicating that the 11-year-long bull market might soon end. These ETFs may, however, survive the crash.

• PSK Quick QuotePSKPositive Net Change
• CLIX Quick QuoteCLIXPositive Net Change
• IDNA Quick QuoteIDNAPositive Net Change

Wall Street in Correction: 4 Sector ETFs Unscathed in February

by Sanghamitra Saha Published on February 28,2020

These sector ETFs gained or lost the least in the coronavirus-induced rout in February.

• TSLA Quick QuoteTSLAPositive Net Change
• GLD Quick QuoteGLDNegative Net Change
• ENPH Quick QuoteENPHNegative Net Change
• SEDG Quick QuoteSEDGPositive Net Change
• TAN Quick QuoteTANPositive Net Change
• SGDM Quick QuoteSGDMNegative Net Change
• CLIX Quick QuoteCLIXPositive Net Change
• KURE Quick QuoteKUREPositive Net Change
• CNRG Quick QuoteCNRGPositive Net Change
• IDNA Quick QuoteIDNAPositive Net Change

• retail

Will Biotech ETFs Excel in Election Year Post a Surge in 2019?

by Sanghamitra Saha Published on December 23,2019

Can biotech ETFs repeat its success story of 2019 in the election year of 2020?

• CNCR Quick QuoteCNCRPositive Net Change
• BBC Quick QuoteBBCNegative Net Change
• PBE Quick QuotePBEPositive Net Change
• IBB Quick QuoteIBBPositive Net Change
• XBI Quick QuoteXBIPositive Net Change
• SBIO Quick QuoteSBIOPositive Net Change
• IDNA Quick QuoteIDNAPositive Net Change
• HTEC Quick QuoteHTECPositive Net Change

• etfs
• medical

Genomics ETFs Surge on CRISPR's Gene Editing Progress

by Sweta Jaiswal, FRM Published on November 25,2019

The release of encouraging data on the CRISPR/Cas9 gene-editing therapy CTX001 for two severe blood disorders puts emphasis on some genomic ETFs.

• PBE Quick QuotePBEPositive Net Change
• VRTX Quick QuoteVRTXPositive Net Change
• CRSP Quick QuoteCRSPPositive Net Change
• ARKG Quick QuoteARKGPositive Net Change
• IDNA Quick QuoteIDNAPositive Net Change
• GNOM Quick QuoteGNOMPositive Net Change

• biotechs
• etfs

Value Biotech ETFs & Stocks to Buy Now

by Sanghamitra Saha Published on November 04,2019

Biotech valuation looks attractive amid a volley of good news. Investors can tap these stocks and ETFs.

• ABBV Quick QuoteABBVPositive Net Change
• BMY Quick QuoteBMYPositive Net Change
• MRK Quick QuoteMRKNegative Net Change
• RHHBY Quick QuoteRHHBYPositive Net Change
• LLY Quick QuoteLLYPositive Net Change
• GSK Quick QuoteGSKPositive Net Change
• XBI Quick QuoteXBIPositive Net Change
• BBH Quick QuoteBBHPositive Net Change
• AMGN Quick QuoteAMGNPositive Net Change
• BIIB Quick QuoteBIIBNegative Net Change
• CELG Quick QuoteCELGPositive Net Change
• IDNA Quick QuoteIDNAPositive Net Change

• etfs
• medical

Biotech ETFs Surge on a Flurry of Positive News

by Sweta Killa Published on October 23,2019

The biotech sector got a boost over the past week from a flurry of positive news including trial results and deal activities.

• XBI Quick QuoteXBIPositive Net Change
• BTEC Quick QuoteBTECNegative Net Change
• BBC Quick QuoteBBCNegative Net Change
• BBP Quick QuoteBBPPositive Net Change
• SBIO Quick QuoteSBIOPositive Net Change
• SPY Quick QuoteSPYPositive Net Change
• ACHN Quick QuoteACHNNegative Net Change
• BIIB Quick QuoteBIIBNegative Net Change
• ALXN Quick QuoteALXNPositive Net Change
• HEPA Quick QuoteHEPANegative Net Change
• IDNA Quick QuoteIDNAPositive Net Change

• biotechs
• etfs

ETFs Poised to Benefit from Gene Editing Revolution

by Sweta Jaiswal, FRM Published on September 06,2019

Rising investments and growing technological advancement are favoring the genomic editing space. We take a look at a few ETFs that can cash in on this trend.

• AGN Quick QuoteAGNPositive Net Change
• PBE Quick QuotePBEPositive Net Change
• ONCE Quick QuoteONCEPositive Net Change
• EDIT Quick QuoteEDITPositive Net Change
• ARKG Quick QuoteARKGPositive Net Change
• GNOM Quick QuoteGNOMPositive Net Change
• IDNA Quick QuoteIDNAPositive Net Change

• biotechs
• etfs

ETFs to Gain From the Booming Genomics Market

by Sweta Jaiswal, FRM Published on September 04,2019

Rising investments, surging demand for personalized medicines and shrinking sequencing costs are a slew of factors favouring the genomics space. We look at a few ETFs that can cash in on this trend.

• PBE Quick QuotePBEPositive Net Change
• ILMN Quick QuoteILMNPositive Net Change
• IDNA Quick QuoteIDNAPositive Net Change
• GNOM Quick QuoteGNOMPositive Net Change
• ARKG Quick QuoteARKGPositive Net Change

• etfs